נובוגרד 2 מ"ג/500 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

METFORMIN HYDROCHLORIDE 500 MG; REPAGLINIDE 2 MG

Disponible desde:

NOVO NORDISK LTD

Código ATC:

A10BA02

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

NOVO NORDISK A/S, DENMARK

Grupo terapéutico:

METFORMIN

indicaciones terapéuticas:

NovoGard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin HCl or who have inadequate glycemic control on a meglitinide alone or metformin HCl alone.

Fecha de autorización:

2011-05-01